These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3308579)

  • 1. Buffy coat transfusions in early type I diabetes.
    Cavanaugh J; Chopek M; Binimelis J; Leiva A; Barbosa J
    Diabetes; 1987 Oct; 36(10):1089-93. PubMed ID: 3308579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results.
    Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F
    Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte transfusion in recent onset type I diabetes mellitus--a one-year follow-up of cell-mediated anti-islet cytotoxicity and C-peptide secretion.
    Krug J; Verlohren HJ; Bierwolf B; Lampeter E; Borte M; Nietzschmann U; Haustein B; Lohmann D
    J Autoimmun; 1990 Oct; 3(5):601-9. PubMed ID: 2252528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
    Huth E
    Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients.
    Agner T; Damm P; Binder C
    Diabetes Care; 1987; 10(2):164-9. PubMed ID: 3556104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of early cyclosporin therapy in juvenile IDDM.
    De Filippo G; Carel JC; Boitard C; Bougnères PF
    Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven years of remission in a type I diabetic patient.
    Koivisto VA; Leirisalo-Repo M; Ebeling P; Tuominen JA; Knip M; Turunen U; Mandrup-Poulsen T; Pelkonen R
    Diabetes Care; 1993 Jul; 16(7):990-5. PubMed ID: 8359107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.
    Imagawa A; Hanafusa T; Itoh N; Waguri M; Yamamoto K; Miyagawa J; Moriwaki M; Yamagata K; Iwahashi H; Sada M; Tsuji T; Tamura S; Kawata S; Kuwajima M; Nakajima H; Namba M; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):574-8. PubMed ID: 10333050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.
    Rossini AA; Faustman D; Woda BA; Like AA; Szymanski I; Mordes JP
    J Clin Invest; 1984 Jul; 74(1):39-46. PubMed ID: 6610693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.